<DOC>
	<DOCNO>NCT01681199</DOCNO>
	<brief_summary>The study design assess effect statin atherosclesrosis progression well explore potential mechanism besides lipid modifying , effect inflammation vascular calcification .</brief_summary>
	<brief_title>Fluvastatin AmelIorates aTHerosclerosis Study</brief_title>
	<detailed_description>Carotid IMT use various study ( e.g . ASAP , ARBITER , METEOR ) well accept valid surrogate marker atherosclerosis . The thickness CIMT significantly associate presence extent coronary disease . Slower progression atherosclerosis measure carotid ultrasound also associate low risk nonfatal MI . In meta analysis , every 0.0 1-mm-per-year decrease carotid IMT , significant 18 % reduction risk nonfatal MI . Measurement carotid IMT carry advantage non-invasive easy use good degree reproducibility . Statins show slow progression atherosclerosis even induce regression atherosclerosis . Change carotid IMT statin find correlate extent LDL-C reduction HDL-C increase however non-lipid effect ( e.g . effect inflammation , calcification ) may also play role beneficial effect statins atherosclerosis.Osteopontin ( OPN ) , acidic phosphoprotein , osteoprotegerin ( OPG ) , member tumor necrosis factor-a receptor superfamily , recently demonstrate modulate vascular calcification . Recent study show association serum OPN OPG level cardiovascular disease vulnerable carotid plaque .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>1 . Newly diagnose coronary heart disease 2 . One maximum IMT measurement ≥1.1mm . 3 . Age 45 70 year old 4 . LDLC≥130mg/dL 5 . Not receive regular lipid lower treatment 6 . Written Informed Consent 1 . Myocardial infarction first symptoms coronary heart disease 2 . Patients know hypersensitivity fluvastatin excipients 3 . Pregnancy lactation , woman childbearing potential use effective contraception 4 . Known muscle disease history muscle disease ( e.g . myopathy , myositis , rhabdomyolysis ) and/or serum CK level great 2 x upper limit normal ( ULN ) 5. renal dysfunction 6 . Active liver disease and/or serum transaminase level ( ALT , AST ) great 2x ULN 7 . Any condition investigator consider suitable longterm follow</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>statin</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>Coronary heart disease</keyword>
	<keyword>OPN</keyword>
	<keyword>OPG</keyword>
</DOC>